FDA Accepts NDA for TNX-102 SL, Tonix Nonopioid Analgesic for Fibromyalgia
Tonix Pharmaceuticals announced today that the FDA has accepted the company's New Drug Application for TNX-102 SL (cyclobenzaprine HCl), a nonopioid, centrally acting analgesic for treatment of fibromyalgia pain. The 5.6 mg sublingual tablet developed …